HLB
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
662 Nonhyeon-ro Fl 4, Seoul, Gangnam-gu,...Website
www.hlbpharma.co.krRevenue
$5.6 MillionIndustry
About HLB
HLB Org Chart
Is HLB your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on HLB recently announced quarterly report
Check out if HLB is spiking on competitors!
Click to see if HLB had a recent Job posting/layoffs
Product Launch: Get notified when HLB launches new products
HLB, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at HLB
Check if HLB has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once HLB has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined HLB as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
HLB is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
HLB is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about HLB.
HLB Tech Stack
A closer look at the technologies used by HLB
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding HLB
HLB제약 주식회사 is a leading pharmaceutical company in South Korea, specializing in both prescription and over-the-counter medications. The company focuses on innovation and has a strong R&D pipeline, aiming to provide effective healthcare solutions for its clients, which include healthcare professionals and patients. HLB제약 is committed to social respon... Read More